![Joanna Horobin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 3 M $ in data 31/08/2026
Joanna C.
Horobin is currently an Independent Director at Liquidia Technologies, Inc. since 2019, an Independent Director at Liquidia Corp.
since 2020, and a Member of the Royal College of General Practitioners.
Former roles include Independent Director at Kymera Therapeutics, Inc. from 2018 to 2024, Independent Non-Executive Director at Nordic Nanovector ASA from 2016 to 2023, Independent Director at Vyant Bio, Inc. from 2021 to 2023, Chief Medical Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2015 to 2019, Chief Medical Officer at Verastem, Inc. from 2012 to 2015, President & Director at Syndax Pharmaceuticals, Inc. in 2012, Executive Vice President at CASI Pharmaceuticals, Inc., Chief Operating Officer at CombinatoRx, Inc., Vice President-Oncology at Rhone-Poulenc Rorer, Inc., Director at Nascent Pharmaceuticals, Inc., Director at The University of Manchester, and Non-Executive Chairman at iOnctura SA. Education includes a doctorate from The University of Manchester.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,04% | 16/06/2026 | 39.637 ( 0,04% ) | 3 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LIQUIDIA CORPORATION | Direttore/Membro del Consiglio | 28/06/2020 |
Royal College of General Practitioners
 Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Direttore/Membro del Consiglio | 11/09/2019 |
| Società | Posizione | Fine |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/06/2024 |
| VYANT BIO, INC. | Direttore/Membro del Consiglio | 01/12/2023 |
| THOR MEDICAL | Direttore/Membro del Consiglio | 03/01/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
| VERASTEM, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Nascent Pharmaceuticals, Inc.
 Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals & drugs | Health Technology |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vyant Bio, Inc.
 Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
